|
|
|
|
| | | | USD | EUR | GBP | JPY | 83.44 | 89.46 | 104.56 | 0.53 |
| | | | AED | AUD | CHF | CAD | 17.54 | 49.53 | 64.49 | 50.06 |
| | | | HKD | SAR | SGD | ZAR | 8.28 | 17.22 | 47.46 | 4.57 |
|
|
|
|
|
|
|
|
|
|
|
Industry :
|
Pharmaceuticals & Drugs
|
|
|
|
|
|
|
|
|
|
52-Week-High (Rs.)
|
416.95
|
|
|
|
|
|
|
* BSE PRICES
|
|
|
|
|
|
( Rs. in Million)
|
Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Profit Before Tax | 1,915.90 | 2,362.31 | 1,313.50 | 287.09 | -92.44 | Adjustment | 1,208.76 | 871.19 | 1,097.10 | 995.13 | 893.40 | Changes In working Capital | -754.90 | -1,088.10 | -1,391.37 | -16.49 | 556.56 | Cash Flow after changes in Working Capital | 2,369.76 | 2,145.39 | 1,019.24 | 1,265.73 | 1,357.53 | Cash Flow from Operating Activities | 1,755.92 | 1,735.52 | 821.74 | 1,226.55 | 1,321.34 | Cash Flow from Investing Activities | -2,053.14 | -1,214.13 | -666.97 | -559.47 | -1,037.57 | Cash Flow from Financing Activities | 228.08 | -443.69 | -298.28 | -639.47 | -161.42 | Net Cash Inflow / Outflow | -69.15 | 77.71 | -143.51 | 27.62 | 122.34 | Opening Cash & Cash Equivalents | 169.01 | 91.30 | 234.81 | 207.19 | 84.85 | Cash & Cash Equivalent on Amalgamation / Take over / Merger | 0 | 0 | 0 | 0 | 0 | Cash & Cash Equivalent of Subsidiaries under liquidations | 0 | 0 | 0 | 0 | 0 | Translation adjustment on reserves / op cash balalces frgn subsidiaries | 0 | 0 | 0 | 0 | 0 | Effect of Foreign Exchange Fluctuations | 0 | 0 | 0 | 0 | 0 | Closing Cash & Cash Equivalent | 99.86 | 169.01 | 91.30 | 234.81 | 207.19 |
|
|
|
|
|
|